CC1=NN(c2nc(N)nc(/C(C#N)=C\c3ccc(-c4ccc([N+](=O)[O-])cc4)o3)n2)C(C)(C)C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?